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INTRODUCTION
Nasal polyps are a prevalent medical condition, affecting 1-4%
of the population. Controversies persist regarding the manage-
ment of nasal polyps because the exact etiology remains unclear.
Corticosteroids are beneficial in reducing the size of polyps and
preventing recurrences, but proper control of nasal polyposis is
a challenging task in clinical situations. It has been reported that
the recurrence rate is as high as 60% in patients with severe
nasal polyposis (1). Nasal polyps are characterized by stromal
edema and increased inflammatory cells. Hyperabsorption of
Na
+ and increased Cl
- permeability may account for stromal
edema formation (2). 
There are two main families of purinergic receptors (adeno-
sine and P2 receptors). The P2 receptors can in turn be divided
into two families (ligand-gated P2X and the G protein-coupled
P2Y receptors). To date, seven P2X receptors (P2X1-7) and eight
P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11-14) have been
cloned and characterized, and are accepted as valid members in
mammals (3). The activation of chloride secretion via purinergic
receptors has been reported in the ciliated respiratory epithelial
cells cultured from nasal polyps (4). On the other hand, there
are reports that the nitric oxide (NO) inhibits Na
+ absorption in
rat cortical collecting ducts (5) and rat distal lung epithelium (6),
while NO activates the cystic fibrosis transmembrane conduc-
tance regulator (CFTR) current in human T lymphocytes (7). The
total amount of NO is higher in polyps than normal mucosa (8),
and inducible nitric oxide synthase (iNOS) is highly expressed
in nasal polyps (9). The aim of the present study was to exam-
ine the effects of ion transport modulators, including purinergic
agonists, NO donors, and the CFTR chloride channel activator
on nasal polyps in situ using a voltage-sensitive vibrating probe
technique.
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Objectives. To examine possible modulators of the ion transport through the apical membrane of the nasal polyps.
Methods. The study was conducted using the freshly-excised nasal polyps from the patients with chronic sinusitis. A volt-
age-sensitive vibrating probe technique was introduced to monitor the short-circuit current across the apical mem-
brane of the polyp at 37℃.
Results. In the presence of amiloride, Adenosine 5’-triphosphate induced 4,4’-Diisothiocyanatostilbene-2,2’-disulfonic acid-
sensitive chloride current. Uridine 5’-diphosphate was less potent than Uridine 5’-triphosphate, and adenosine increased
chloride secretion, which was blocked by the antagonist, 8-(p-sulfophenyl) theophylline on adenosine receptor. Based
on the pharmacologic profiles, multiple purinergic receptors, including P2Y2, P2Y6, and P1 receptors, were functionally
expressed. However, P2X receptor agonists ( , -methyleneadenosine 5’-triphosphate and 2’- & 3’-O-[4-benzoyl-ben-
zoyl] adenosine 5’-triphosphate), Cystic fibrosis conductance regulator (CFTR) activator (genistein), nitric oxide substrate
(L-arginine), and nitric oxide donor (sodium nitroprusside) had no significant effect on the short circuit current.
Conclusion. Among tested drugs, P2Y receptor agonists were major modulators of ion transport in nasal polyps in situ.
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Original ArticleMATERIALS AND METHODS
The polyps were freshly obtained from patients with chronic
sinusitis during endoscopic sinus surgery and were immediately
delivered to the laboratory in cold physiologic saline. No local
anesthetic agents were introduced before extirpating the polyps.
The submucosa of the polyp was removed under a stereomicro-
scope and the tissue was divided into several small pieces. The
tissue was folded with the apical membrane of the surface ciliat-
ed epithelium facing outward and transferred into a recording
chamber. Our Institutional Committee approved the use of these
tissues with informed consent.
The vibrating probe is a technique for measuring extracellu-
lar electrical currents that are steady or slowly changing. The
diameter of the vibrating probe tip is about 20 μ m and allows
the detection of voltages in the low nanovolt range; vibration
between two positions within the line of current flow yields
voltages that correspond to current flow through resistive phys-
iologic saline. The technique has been described in detail else-
where (10). Briefly, the short circuit current (Isc) was monitored
by vibrating a platinum-iridium wire microelectrode that was
insulated with parlene-C (Micro Electrodes, Gaithersburg, MD,
USA) and which had been coated with platinum black on the
exposed tip. The vibration was about 20 μ m along both a hori-
zontal (X) and vertical (Z) axis. The X-axis was perpendicular to
the face of the epithelium. The probe was positioned 30-40 μ m
from the apical surface of the epithelium with computer-con-
trolled, stepper-motor manipulators (Applicable Electronics,
Forestdale, MA, USA) and specialized probe software (ASET,
version 2.0, Science Wares, East Falmouth, MA, USA). The bath
references were 26-gauge platinum-black electrodes. Calibration
was performed in physiologic saline (see below) using a glass
microelectrode (tip, < 1 μ m OD) filled with 3 M KCl as a point
source of the current. The frequencies of vibration were in the
range of 300-400 Hz and were well-separated for the two orthogo-
nal directions. The signals from the oscillators driving the probe
were also fed to a dual channel phase-sensitive detector. The
signal of the X and Z detectors were connected to a 16 bit ana-
log to digital converter (CIO-DAS1602/16, ComputerBoards,
Mansfield, MA, USA) in a Pentium IV computer. The sampling
interval was 0.6s, which is the minimum in this software. The
electrode was positioned such that Isc showed a maximum X
value and a minimum Z value; data are expressed as the vector
length of the current density and plotted with Origin software,
version 6.1 (OriginLab Software, Northampton, MA, USA). The
output from the vibrating probe depends not only on the spe-
cific short circuit current of the epithelium, but also on the posi-
tion of the probe from the surface of the tissue and the exact
geometry of each tissue sample. The current density reported
here refers to the flux at the position of the probe and repre-
sents only a fraction of the current crossing the epithelium. No
changes in the relative position of the probe due to swelling or
shrinking of the tissue during experimental treatments were
observed.
In all experiments, both sides of the polyp were perfused with
physiologic saline containing (in mM) 130 NaCl, 5 KCl, 1 MgCl2,
1 CaCl2, 5 glucose, and 10 HEPES (pH 7.4). Adenosine 5’-tri-
phosphate (ATP), uridine 5’-triphosphate (UTP), 2’- and 3’-O-
(4-benzoyl-benzoyl)adenosine 5’-triphosphate (BzATP), α ,β -
methyleneadenosine 5’-triphosphate α β meATP), 4,4′ -diisothio-
cyanatostilbene-2,2′ -disulfonic acid disodium salt hydrate (DIDS),
L-arginine, sodium nitroprusside (SNP), and 8-(p-sulfophenyl)
theophylline (8-SPT) were directly dissolved in physiologic saline
just before use. Uridine 5’ -diphosphate (UDP) was pre-incubat-
ed for 1.5 h with hexokinase (1 unit/mL) and glucose (5 mM)
because the commercial preparations of UDP may be supplied
with a minor component of UTP (11). Amiloride, N-phenylan-
thranilic acid (DPC), genistein, and ouabain were dissolved in
DMSO and then diluted to 0.1% DMSO in the control solution
prior to application. DMSO at this concentration had no effect
on the Isc.
Each tissue was mounted in a perfusion chamber on the stage
of an inverted microscope and continuously perfused at 37℃at
an exchange rate of 0.7 times/sec. Ouabain (10 μ M), an inhibitor
of Na
+, K
+-ATPase, was tested to estimate the time for the per-
fusate to migrate to the basolateral membrane of the surface
epithelium. Application of ouabain decreased the Isc from 8.6±
2.5 min (n=15), which indicates that the ion channel modula-
tors used here acted in a short time on the apical membrane of
surface epithelium.
For analysis, the peak Isc was chosen. Data are expressed as
the mean±S.E.M. (n=number of tissues) of the Isc. An increase
or decrease in Isc were considered significant at a level of P<0.05.
A paired t-test was used. 
RESULTS
The Isc measured in physiologic saline was -124.0±17.0 μ A/cm
2
(n=33). Perfusion of amiloride (100 μ M), an epithelial sodium
channel (ENaC) blocker, significantly decreased the Isc by 78.7±
3.1% (to -18.8±2.6 μ A/cm
2, n=33). In the presence of amiloride,
DIDS (1.5 mM) slightly decreased the Isc by 11.1±2.5% (n=17)
and subsequent application of DPC (0.5 mM) significantly dec-
reased the Isc by 88.0±2.6% (n=17, Fig. 1A). In the presence of
amiloride, 100 μ M ATP significantly increased the Isc by 460.1
±171.8% (n=7), which was inhibited by DPC (92.1±1.8%),
but not by DIDS (17.9±6.7%, Fig. 1B).
ATP and UTP increased the Isc in a dose-dependent manner
(Fig. 2). The EC50 of ATP and UTP was 5.3±0.3 (n=5) and 7.7
±0.8 μ M (n=5), respectively. UDP, a P2Y6 receptor agonist,
also increased the Isc to 44.5±8.9% of the UTP response (n=5,
Fig. 3A). Adenosine, a purinergic receptor type 1 (P1) receptor
agonist, increased the Isc by 340.1±167.9% (from -21.4±6.6
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2, n=7, Fig. 3B). In the presence of 100 μ M
8-SPT, a P1 receptor blocker, the response of adenosine was
decreased by 90.0±3.7% (from -50.0±5.5 to -23.4±6.5 μ A/
cm
2, n=7, Fig. 3B).
P2X receptor agonists and other modulators for ion transport
were introduced to test the effects on polyps (Fig. 4). The addi-
tion of α β meATP and BzATP (100 μ M) had no significant res-
ponse in the presence of amiloride (from -13.2±4.5 to -13.9±
3.9 μ A/cm
2 and -12.7±2.5 to -12.4±2.5 μ A/cm
2, respectively,
n=5 each, Fig. 4A). The addition of genistein (20 μ M), the CFTR
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Fig. 1. Effects of DIDS, DPC, and ATP in the presence of amiloride on the Isc. (A) A raw trace representative of 17 experiments was shown. The
majority of the remained Isc in the presence of amiloride is accounted for by DPC-sensitive chloride conductance. (B) Effects of DIDS and DPC
on the Isc after activation of chloride secretion by ATP in the presence of amiloride. A raw trace representative of 7 experiments was shown.
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Fig. 2. Dose-response relationships of ATP (A) and UTP (B) in the pres-
ence of amiloride. (C) EC50 of ATP (dashed line) and UTP (continu-
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Agonist ( M)activator (12), had no effect on the Isc (from -14.1±2.5 to -14.4
±2.9 μ A/cm
2, n=6, Fig. 4A). Perfusion of L-arginine (1 mM, sub-
strate for nitric oxide synthase, n=5) and sodium nitroprusside
(1 mM, nitric oxide donor, n=7) showed no response in the
absence (-101.7±20.7 μ A/cm
2 to -95.8±22.3 μ A/cm
2, -122.1
±19.6 μ A/cm
2 to -118.8±20.5 μ A/cm
2, respectively) and pres-
ence (from -19.8±4.6 to -18.9±4.3 μ A/cm
2, -18.8±4.6 to -18.9
±4.3 μ A/cm
2, respectively, Fig. 4B) of amiloride.
DISCUSSION
The Isc measured in polyps largely represents the current from
the ciliated epithelial cells because the superficial epithelium of
the polyp is characterized by ~80% ciliated cells (13). The block-
ade of Na
+ absorption by amiloride is consistent with a previ-
ous report involving nasal polyps in situ (14). In the presence of
amiloride, DIDS had little effect on the Isc, but DPC abolished
the Isc. Although DIDS and DPC are non-specific anion channel
blockers, current pharmacology indicates that DIDS does not
act on the CFTR chloride channel, even at high concentrations
(15), and DPC induces a voltage-dependent blockade of CFTR
when used at micromolar concentrations (16). Therefore, after
the addition of amiloride the Isc is likely to be dominated by
CFTR-mediated chloride conductance. ATP strongly stimulated
DPC-sensitive chloride secretion and its potency was similar to
UTP. This is consistent with the activation of the human P2Y2
receptor (17) because ATP acts as a competitive antagonist on
the human P2Y4 receptor (18). The EC50 of ATP and UTP mea-
sured in this study was 5.3 and 7.3 μ M, respectively, which was
similar to the EC50 reported in cultured cells in terms of anion
transport (ATP, 1.0 μ M) (19) and ciliary beat frequency (UTP,
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Fig. 3. Effects of ATP, UTP, UDP, and adenosine on the Isc. (A) A representative trace of 5 experiments. UDP acting on P2Y6 receptors was less
potent than UTP on P2Y2 receptors. UDP was preincubated with hexokinase in the presence of glucose to eliminate small amount of UTP cont-
amination. (B) Effect of adenosine in the presence of amiloride on the Isc. Adenosine (Ad) also activated chloride secretion, which was inhibited
by a nonspecific blocker (8-SPT).
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Fig. 4. Effects of P2X agonists, genistein (A), and nitric oxide donors (B) in the presence of amiloride on the Isc. None of these agents had an effect
on the nasal polyps in situ. (A) α β meATP, BzATP (100  M), and genistein (20  M) were used. (B) L-arginine (L-arg, 1 mM), sodium nitroprus-
side (SNP, 1 mM), and ATP (100  M) were used.
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A B4.7 μ M) (20). UDP, the principal agonist for P2Y6, increased the
chloride secretion to 44% of the UTP response, which is similar
magnitude in magnitude in terms of ciliary beat frequency (20).
This finding indicates that the P2Y6 receptor is likely to be active.
Besides, we have eliminated the possibility of UTP contamina-
tion from UDP preparation by addition of hexokinase and glu-
cose. This point was not clearly noted in the previous reports
concerning P2Y6 characterization in the airway epithelium (20).
Another P1 purinergic agonist, adenosine, also activated chlo-
ride secretion, which was inhibited by a non-specific adenosine
receptor blocker, 8-SPT (21).
We examined further how much P2X receptors are function-
ally implicated in nasal polyp using α β meATP and BzATP. The
α β ATP is an agonist for P2X1 and P2X3, and BzATP is for
P2X1, P2X2, and P2X7 (22). P2X receptors could not be detect-
ed pharmacologically, which indicates that P2X receptors do
not have a significant role compared to P2Y receptors. This is
contrary to the report which described these agonists having
large responses in lung-derived cultured cells (23). The CFTR
activator, genistein (24), did not induce a CFTR current, which
may be attributed to an altered localization of CFTR in the nasal
polyp (25). If NO, generated by the application of NO substrate
(L-arginine) or NO donor (SNP), has a regulatory effect on the
CFTR or ENaC, it can serve as a medical, therapeutic strategy
for nasal polyps. However, there was no beneficial effect at high
concentrations of L-arginine and SNP, both in the absence and
presence of amiloride in nasal polyps, which is similar to the
observation in cultured human nasal epithelium (26).
In conclusion, the multiple P2Y receptors were functioning at
the apical membrane of the nasal polyp in situ. However, P2X
agonists, the CFTR activator, and NO-producing drugs did not
have a beneficial effect on nasal polyps in situ. 
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